Literature DB >> 2240094

Antinuclear antibodies in sera of patients with recurrent pregnancy wastage.

L Xu1, V Chang, A Murphy, J A Rock, M Damewood, W Schlaff, H A Zacur.   

Abstract

Four groups of women were studied to determine whether low-level antinuclear antibody titers are associated with a higher risk for pregnancy loss. Group A consisted of 30 patients with a history of unexplained fetal losses. Group B consisted of 30 women with "explained" fetal losses (e.g., uterine septum or luteal phase defect). Ages and number of losses were comparable between the women in groups A and B. Group C consisted of 61 healthy pregnant women. Group D involved 61 healthy nonpregnant women of reproductive age. In groups A and B, 40% and 53.3% of the respective patients had antinuclear antibody titers greater than or equal to 1:40. In groups C and D the frequencies of positive antinuclear antibody titers were 8.2% and 5.6%, respectively. This study demonstrates a high prevalence of low-titer antinuclear antibody-positive serum in patients with explained and unexplained pregnancy losses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240094     DOI: 10.1016/0002-9378(90)90612-b

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Autoimmune Regulator is required in female mice for optimal embryonic development and implantation†.

Authors:  Bryce D Warren; Soo H Ahn; Lynda K McGinnis; Geoffrey Grzesiak; Ren-Wei Su; Asgerally T Fazleabas; Lane K Christenson; Brian K Petroff; Margaret G Petroff
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

2.  Antinuclear antibodies and breast implants.

Authors:  H N Claman; A D Robertson
Journal:  West J Med       Date:  1994-03

3.  Autoantibody profile and other immunological parameters in recurrent spontaneous abortion patients.

Authors:  U Shankarkumar; V D Pradhan; M M Patwardhan; A Shankarkumar; K Ghosh
Journal:  Niger Med J       Date:  2011-07

4.  The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials.

Authors:  Pia Egerup; Jane Lindschou; Christian Gluud; Ole Bjarne Christiansen
Journal:  Syst Rev       Date:  2014-08-15

5.  Uterine blood flow indices, antinuclear autoantibodies and unexplained recurrent miscarriage.

Authors:  A Pietropolli; Valentina Bruno; M V Capogna; S Bernardini; E Piccione; C Ticconi
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

Review 6.  Allergen-specific IgG as a mediator of allergy inhibition: Lessons from mother to child.

Authors:  Jefferson Russo Victor
Journal:  Hum Vaccin Immunother       Date:  2016-11-03       Impact factor: 3.452

7.  Serum leptin levels in women with immunological recurrent abortion.

Authors:  Zarei Saeed; Soltanghoraee Haleh; Mohammadzadeh Afsaneh; Arefi Soheila; Zarnani Amir Hassan; Idali Farah; Tavangar Banafsheh; Savadi Shiraz Elham; Moshref Behzad Narges; Jeddi-Tehrani Mahmood
Journal:  J Reprod Infertil       Date:  2010-04

Review 8.  Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis.

Authors:  Denise H J Habets; Kim Pelzner; Lotte Wieten; Marc E A Spaanderman; Eduardo Villamor; Salwan Al-Nasiry
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-11       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.